QS Investors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $361K | Sell |
2,124
-200
| -9% | -$34K | ﹤0.01% | 865 |
|
|
2021
Q1 | $329K | Hold |
2,324
| – | – | ﹤0.01% | 953 |
|
|
2020
Q4 | $302K | Buy |
2,324
+224
| +11% | +$29.1K | ﹤0.01% | 988 |
|
|
2020
Q3 | $306K | Sell |
2,100
-500
| -19% | -$72.9K | ﹤0.01% | 908 |
|
|
2020
Q2 | $386K | Buy |
2,600
+200
| +8% | +$29.7K | 0.01% | 975 |
|
|
2020
Q1 | $262K | Hold |
2,400
| – | – | ﹤0.01% | 999 |
|
|
2019
Q4 | $278K | Hold |
2,400
| – | – | ﹤0.01% | 1103 |
|
|
2019
Q3 | $194K | Hold |
2,400
| – | – | ﹤0.01% | 1210 |
|
|
2019
Q2 | $175K | Hold |
2,400
| – | – | ﹤0.01% | 1253 |
|
|
2019
Q1 | $225K | Sell |
2,400
-8
| -0.3% | -$750 | ﹤0.01% | 1178 |
|
|
2018
Q4 | $176K | Hold |
2,408
| – | – | ﹤0.01% | 1166 |
|
|
2018
Q3 | $211K | Hold |
2,408
| – | – | ﹤0.01% | 1190 |
|
|
2018
Q2 | $237K | Hold |
2,408
| – | – | ﹤0.01% | 1155 |
|
|
2018
Q1 | $287K | Hold |
2,408
| – | – | ﹤0.01% | 1074 |
|
|
2017
Q4 | $306K | Hold |
2,408
| – | – | ﹤0.01% | 1064 |
|
|
2017
Q3 | $283K | Hold |
2,408
| – | – | ﹤0.01% | 1103 |
|
|
2017
Q2 | $192K | Buy |
2,408
+900
| +60% | +$71.8K | ﹤0.01% | 1227 |
|
|
2017
Q1 | $77K | Buy |
1,508
+1,500
| +18,750% | +$76.6K | ﹤0.01% | 1434 |
|
|
2016
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 1525 |
|
|
2016
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 1511 |
|
|
2016
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 1532 |
|
|
2016
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 1531 |
|
|
2015
Q4 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 1539 |
|
|
2015
Q3 | – | Sell |
-17,100
| Closed | -$2.05M | – | 1436 |
|
|
2015
Q2 | $2.05M | Buy |
+17,100
| New | +$2.05M | 0.03% | 612 |
|
|
2013
Q3 | – | Sell |
-136,100
| Closed | -$4.22M | – | 585 |
|
|
2013
Q2 | $4.22M | Buy |
+136,100
| New | +$4.22M | 0.15% | 188 |
|